REAL-LIFE EFFECTIVENESS OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA

被引:0
|
作者
Dominguez, L. [1 ]
Valera-Rubio, M. [2 ]
Madronal, Carrion, I [1 ]
机构
[1] Hosp Virgen Macarena, Seville, SE, Spain
[2] Hosp Univ Virgen Macarena, Seville, Spain
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
CO99
引用
收藏
页码:S32 / S32
页数:1
相关论文
共 50 条
  • [1] IBRUTINIB IN THE MANAGEMENT OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A REAL-LIFE MONOCENTRIC EXPERIENCE
    Albi, E.
    Del Papa, B.
    Dorillo, E.
    Aureli, P.
    Cantelmi, M. G.
    Zei, T.
    Ostini, R. Iacucci
    Ciurnelli, R.
    Falzetti, F.
    Sportoletti, P.
    [J]. HAEMATOLOGICA, 2017, 102 : 123 - 123
  • [2] Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data
    Tombak, Anil
    Tanrikulu, Funda Pepedil
    Durusoy, Salih Sertac
    Dincyurek, Huseyin Derya
    Kaya, Emin
    Umit, Elif Gulsum
    Yavasoglu, Irfan
    Mehtap, Ozgur
    Deveci, Burak
    Ozcan, Mehmet Ali
    Terzi, Hatice
    Okay, Mufide
    Sayinalp, Nilgun
    Yilmaz, Mehmet
    Okan, Vahap
    Kizikli, Alperen
    Ozcan, Omer
    Cetin, Guven
    Demircioglu, Sinan
    Aydogdu, Ismet
    Saydam, Guray
    Davulcu, Eren Arslan
    Ilhan, Gul
    Ucar, Mehmet Ali
    Ozet, Gulsum
    Akpinar, Seval
    Turgut, Burhan
    Berber, Ilhami
    Kurtoglu, Erdal
    Sonmez, Mehmet
    Batur, Derya Selim
    Yildirim, Rahsan
    Ozkocamaz, Vildan
    Gunes, Ahmet Kursad
    Sahip, Birsen
    Ertop, Sehmus
    Akay, Olga Meltem
    Basturk, Abdulkadir
    Dogu, Mehmet Hilmi
    Akdeniz, Aydan
    Unal, Ali
    Seyhanli, Ahmet
    Gurkan, Emel
    Cekdemir, Demet
    Ferhanoglu, Burhan
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (04) : 273 - 285
  • [3] Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases
    Morabito, Fortunato
    Tripepi, Giovanni
    Del Poeta, Giovanni
    Mauro, Francesca Romana
    Reda, Gianluigi
    Sportoletti, Paolo
    Laurenti, Luca
    Coscia, Marta
    Herishanu, Yair
    Bossio, Sabrina
    Varettoni, Marzia
    Murru, Roberta
    Chiarenza, Annalisa
    Visentin, Andrea
    Condoluci, Adalgisa
    Moia, Riccardo
    Pietrasanta, Daniela
    Loseto, Giacomo
    Consoli, Ugo
    Scortechini, Ilaria
    Rossi, Francesca Maria
    Zucchetto, Antonella
    Al-Janazreh, Hamdi
    Vigna, Ernesto
    Martino, Enrica Antonia
    Mendicino, Francesco
    Cassin, Ramona
    D'Arrigo, Graziella
    Galimberti, Sara
    Rago, Angela
    Angeletti, Ilaria
    Biagi, Annalisa
    Del Giudice, Ilaria
    Bomben, Riccardo
    Neri, Antonino
    Fronza, Gilberto
    Monti, Paola
    Menichini, Paola
    Cutrona, Giovanna
    Jaksic, Ozren
    Rossi, Davide
    Di Raimondo, Francesco
    Cuneo, Antonio
    Gaidano, Gianluca
    Polliack, Aaron
    Trentin, Livio
    Foa, Robin
    Ferrarini, Manlio
    Gattei, Valter
    Gentile, Massimo
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) : 493 - 499
  • [4] Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
    Roeker, Lindsey E.
    DerSarkissian, Maral
    Ryan, Kellie
    Chen, Yan
    Duh, Mei Sheng
    Wahlstrom, Svea K.
    Hakre, Shweta
    Yu, Louise
    Guo, Helen
    Mato, Anthony R.
    [J]. BLOOD ADVANCES, 2023, 7 (16) : 4291 - 4301
  • [5] Ibrutinib for Chronic Lymphocytic Leukemia
    Rigolin, Gian Matteo
    Cavazzini, Francesco
    Cuneo, Antonio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (16): : 1593 - 1593
  • [6] Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study
    Massimo Gentile
    Fortunato Morabito
    Giovanni Del Poeta
    Francesca Romana Mauro
    Gianluigi Reda
    Paolo Sportoletti
    Luca Laurenti
    Marta Coscia
    Yair Herishanu
    Anna Grazia Recchia
    Marzia Varettoni
    Roberta Murru
    Annalisa Chiarenza
    Adalgisa Condoluci
    Riccardo Moia
    Daniela Pietrasanta
    Giacomo Loseto
    Ugo Consoli
    Ilaria Scortechini
    Francesca Maria Rossi
    Antonella Zucchetto
    Vincenzo Fraticelli
    Ernesto Vigna
    Cirino Botta
    Giovanni Tripepi
    Graziella D’ Arrigo
    Angela Rago
    Ilaria Angeletti
    Annalisa Biagi
    Ilaria Del Giudice
    Riccardo Bomben
    Gian Matteo Rigolin
    Davide Rossi
    Francesco Di Raimondo
    Gianluca Gaidano
    Aaron Polliack
    Antonio Cuneo
    Robin Foà
    Valter Gattei
    [J]. Leukemia, 2021, 35 : 235 - 238
  • [7] Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study
    Gentile, Massimo
    Morabito, Fortunato
    Del Poeta, Giovanni
    Mauro, Francesca Romana
    Reda, Gianluigi
    Sportoletti, Paolo
    Laurenti, Luca
    Coscia, Marta
    Herishanu, Yair
    Recchia, Anna Grazia
    Varettoni, Marzia
    Murru, Roberta
    Chiarenza, Annalisa
    Condoluci, Adalgisa
    Moia, Riccardo
    Pietrasanta, Daniela
    Loseto, Giacomo
    Consoli, Ugo
    Scortechini, Ilaria
    Rossi, Francesca Maria
    Zucchetto, Antonella
    Fraticelli, Vincenzo
    Vigna, Ernesto
    Botta, Cirino
    Tripepi, Giovanni
    D'Arrigo, Graziella
    Rago, Angela
    Angeletti, Ilaria
    Biagi, Annalisa
    Del Giudice, Ilaria
    Bomben, Riccardo
    Rigolin, Gian Matteo
    Rossi, Davide
    Di Raimondo, Francesco
    Gaidano, Gianluca
    Polliack, Aaron
    Cuneo, Antonio
    Foa, Robin
    Gattei, Valter
    [J]. LEUKEMIA, 2021, 35 (01) : 235 - 238
  • [8] Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
    Neffendorf, James E.
    Gout, Irina
    Hildebrand, G. Darius
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (13): : 1277 - 1277
  • [9] Ibrutinib for the treatment of chronic lymphocytic leukemia
    Deodato, Marina
    Frustaci, Anna Maria
    Zamprogna, Giulia
    Cairoli, Roberto
    Montillo, Marco
    Tedeschi, Alessandra
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (05) : 273 - 284
  • [10] Ibrutinib for treatment of chronic lymphocytic leukemia
    Vela, Cory M.
    McBride, Ali
    Jaglowski, Samantha M.
    Andritsos, Leslie A.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (06) : 367 - 375